Evidence map›Paper›PMID 18218820›Full record

ArticleStem cells (Dayton, Ohio)2008

Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects.

Zongjin Li, Yoriyasu Suzuki, Mei Huang, Feng Cao, Xiaoyan Xie, Andrew J Connolly, Phillip C Yang, Joseph C Wu

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Stem cells (Dayton, Ohio), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 214 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Generation of In Vivo Traceable Hepatocyte-Like Cells from Human iPSCs.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Article
  9. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Review
  10. Article
  11. How Non-invasiveFrontiers in physiology · 2020
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Stem Cells and Labeling for Spinal Cord Injury.International journal of molecular sciences · 2016
    Review
  18. Review
  19. PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Article
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zongjin LiDepartment of Radiology and Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California 94305-5344, USA.
Yoriyasu Suzuki
Mei Huang
Feng Cao
Xiaoyan Xie
Andrew J Connolly
Phillip C Yang
Joseph C Wu
Stanford Medicine · USStanford University · US

Funding

Nanostructuring and Molecular Imaging of Engineered Cardiovascular TissuesR33HL089027 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2011
$2.3M
Nanostructuring and Molecular Imaging of Engineered Cardiovascular TissuesR21HL089027 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2007 to 2008
$777k
Molecular Imaging of Cardiac Cell TransplantationK08HL074883 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2005 to 2008
$531k
NHLBI NIH HHS HL074883NHLBI NIH HHS HL089027NHLBI NIH HHS K08 HL074883NHLBI NIH HHS R21 HL089027NHLBI NIH HHS R33 HL089027
6 · The paper itself

Abstract

Human embryonic stem (hES) cells are pluripotent stem cells capable of self-renewal and differentiation into virtually all cell types. Thus, they hold tremendous potential as cell sources for regenerative therapies. The concurrent development of accurate, sensitive, and noninvasive technologies capable of monitoring hES cells engraftment in vivo can greatly expedite basic research prior to future clinical translation. In this study, hES cells were stably transduced with a lentiviral vector carrying a novel double-fusion reporter gene that consists of firefly luciferase and enhanced green fluorescence protein. Reporter gene expression had no adverse effects on cell viability, proliferation, or differentiation to endothelial cells (human embryonic stem cell-derived endothelial cells [hESC-ECs]). To compare the two popular imaging modalities, hES cells and hESC-ECs were then colabeled with superparamagnetic iron oxide particles before transplantation into murine hind limbs. Longitudinal magnetic resonance (MR) imaging showed persistent MR signals in both cell populations that lasted up to 4 weeks. By contrast, bioluminescence imaging indicated divergent signal patterns for hES cells and hESC-ECs. In particular, hESC-ECs showed significant bioluminescence signals at day 2, which decreased progressively over the following 4 weeks, whereas bioluminescence signals from undifferentiated hES cells increased dramatically during the same period. Post-mortem histology and immunohistochemistry confirmed teratoma formation after injection of undifferentiated hES cells but not hESC-ECs. From these data taken together, we concluded that reporter gene is a better marker for monitoring cell viability, whereas iron particle labeling is a better marker for high-resolution detection of cell location by MR. Furthermore, transplantation of predifferentiated rather than undifferentiated hES cells would be more suited for avoiding teratoma formation.

Indexed as

Cell DifferentiationGenes, ReporterAnimalsCell LineCells, CulturedCell SurvivalDextransEmbryonic Stem CellsEndothelial CellsFemaleFerrosoferric OxideGenetic VectorsHumansIronMagnetic Resonance SpectroscopyMagnetite NanoparticlesDextransFerrosoferric OxideferumoxidesIronMagnetite NanoparticlesOxides

Identifiers

PMID18218820
PMCPMC3638035
OpenAlexW2085874686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.